FALANGA ANNA
Ruolo:
Professore straordinario a tempo determinato
Settore scientifico disciplinare:
MALATTIE DEL SANGUE (MED/15)
E-mail:
Didattica
A.A.: 2020/2021
A.A.: 2019/2020
A.A.: 2018/2019
A.A.: 2016/2017
Pubblicazioni
- Crippa, M., Bersini, S., Gilardi, M., Arrigoni, C., Gamba, S., Falanga, A., et al. (2021). A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation. LAB ON A CHIP, 21(6 (21 March 2021)), 1061-1072. Dettaglio
- Giaccherini, C., Marchetti, M., Masci, G., Verzeroli, C., Russo, L., Celio, L., et al. (2020). Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer. HAEMATOLOGICA, 105(6), 1704-1711. Dettaglio
- Palareti, G., Legnani, C., Antonucci, E., Cosmi, B., Poli, D., Testa, S., et al. (2020). D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study. INTERNAL AND EMERGENCY MEDICINE, 15(3), 453-462. Dettaglio
- Thachil, J., Tang, N., Gando, S., Falanga, A., Levi, M., Clark, C., et al. (2020). Laboratory haemostasis monitoring in COVID-19. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(8), 2058-2060. Dettaglio
- Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., et al. (2020). DOACs and “newer” hemophilia therapies in COVID-19: Reply. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(7), 1795-1796. Dettaglio